Schmittgall HEALTH, one of the leading creative agencies in the field of healthcare communication, is delighted to welcome Constanze Dewald as Executive Director Growth. Dewald took up her new position on March 1, 2025 and will strengthen the agency's Management Board.
Constanze Dewald holds a Master of Science in Marketing & Communication and has many years of experience in the healthcare and pharmaceutical industry. She has held leading positions at renowned national and international communications and marketing agencies, including FleishmanHillard, WE Communications and dk Life Science Communications. Her multi-faceted knowledge covers numerous aspects of strategic client consulting and business development.
In her new role as Executive Director Growth at Schmittgall HEALTH, Dewald will play a central role in the strategic development of the agency. In addition to managing and developing business development projects, particularly in the Rx area, and ensuring entrepreneurial goals in the areas of new business and account growth, she will actively shape the corporate strategy and develop new business areas.
"In my new position, I am very much looking forward to further advancing Schmittgall HEALTH's creative and innovative approaches while strengthening client relationships through trust and expertise," says Dewald. "With "Brave for Brands", the agency has a clear stance and enjoys an excellent reputation in the market. I would like to build on this, expand our portfolio and provide fresh impetus for our clients."
Florian Schmittgall, owner and Managing Director of the Schmittgall Group, adds: "With Constanze Dewald as part of our Management Board, we are strengthening our position as one of the top creative agencies in the DACH region. Her strategic mindset and expertise will help us to increase our innovative strength and expand our market presence."
